TOKYO/NEW DELHI (Reuters) – Japanese drug maker Daiichi Sankyo Co Ltd (Tokyo:4568.T – News) moved to take majority control of India’s biggest drug maker Ranbaxy Laboratories Ltd (Bombay:RANB.BO – News) in a friendly deal worth up to $4.6 billion. It represents a major foray into the high growth area of generic drugs by Daiichi Sankyo […] ↓ Read the rest of this entry…